Global Immuno Oncology Assays Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Immuno Oncology Assays market size will reach US$ 11220 million by 2031.
Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
United States market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Immuno Oncology Assays players cover Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Immuno Oncology Assays Industry Forecast” looks at past sales and reviews total world Immuno Oncology Assays sales in 2024, providing a comprehensive analysis by region and market sector of projected Immuno Oncology Assays sales for 2025 through 2031. With Immuno Oncology Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno Oncology Assays industry.
This Insight Report provides a comprehensive analysis of the global Immuno Oncology Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno Oncology Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno Oncology Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno Oncology Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno Oncology Assays.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno Oncology Assays market by product type, application, key players and key regions and countries.
Segmentation by Type:
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Segmentation by Application:
Research
Clinical Diagnostics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
Please note: The report will take approximately 2 business days to prepare and deliver.
Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
United States market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Immuno Oncology Assays players cover Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Immuno Oncology Assays Industry Forecast” looks at past sales and reviews total world Immuno Oncology Assays sales in 2024, providing a comprehensive analysis by region and market sector of projected Immuno Oncology Assays sales for 2025 through 2031. With Immuno Oncology Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno Oncology Assays industry.
This Insight Report provides a comprehensive analysis of the global Immuno Oncology Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno Oncology Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno Oncology Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno Oncology Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno Oncology Assays.
This report presents a comprehensive overview, market shares, and growth opportunities of Immuno Oncology Assays market by product type, application, key players and key regions and countries.
Segmentation by Type:
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Segmentation by Application:
Research
Clinical Diagnostics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
70 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Immuno Oncology Assays Market Size by Player
- 4 Immuno Oncology Assays by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Immuno Oncology Assays Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
